Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Swedbank AB

Swedbank AB lessened its holdings in Doximity, Inc. (NASDAQ:DOCS) by 89.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 167,882 shares of the company’s stock after selling 1,492,526 shares during the period. Swedbank AB’s holdings in Doximity were worth $7,315,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. Farther Finance Advisors LLC lifted its position in Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after buying an additional 603 shares during the last quarter. LRI Investments LLC acquired a new stake in shares of Doximity during the first quarter valued at about $27,000. Blue Trust Inc. raised its stake in shares of Doximity by 621.4% in the 2nd quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock valued at $37,000 after acquiring an additional 1,193 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Doximity by 40.1% in the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after acquiring an additional 412 shares during the last quarter. Finally, Quarry LP boosted its position in shares of Doximity by 101.2% during the 2nd quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after purchasing an additional 131,253 shares during the period. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Canaccord Genuity Group restated a “hold” rating and set a $60.00 price target (up from $40.00) on shares of Doximity in a research note on Wednesday, November 13th. Evercore ISI increased their target price on Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Wells Fargo & Company upgraded Doximity from an “underweight” rating to an “equal weight” rating and raised their target price for the company from $19.00 to $41.00 in a report on Friday, November 8th. Morgan Stanley upgraded shares of Doximity from an “underweight” rating to an “equal weight” rating and boosted their price target for the stock from $33.00 to $53.00 in a research note on Thursday, November 14th. Finally, Baird R W upgraded shares of Doximity to a “strong-buy” rating in a report on Tuesday, September 17th. Eleven equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Doximity presently has a consensus rating of “Hold” and an average target price of $52.27.

Doximity Stock Performance

Shares of NASDAQ DOCS opened at $53.54 on Wednesday. The stock’s 50-day simple moving average is $44.83 and its 200-day simple moving average is $35.34. The firm has a market capitalization of $10.00 billion, a PE ratio of 61.54, a price-to-earnings-growth ratio of 3.91 and a beta of 1.30. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $61.75.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.